The Futility of Prior Authorization
Two independent nationwide surveys, one by the American Medical Association (AMA) and the other from the American College of Rheumatology shows broad physician dissatisfaction with the insidious practices of prior-authorization and step therapy – specifically the ways in which it impacts the ability of physicians to treat patients. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - August 25, 2021 Category: Pharmaceuticals Source Type: blogs
FDA and "Right to Repair" -- Nullum gratuitum grandium.
There ’s going to be a lot more requirements for responsibility and accountability on the part of those medical device owners who oversee, operate and remediate problems When it comes to FDA-regulated medical devices, “Right to Repair, “doesn’t mean “cheap and easy.” The FDA has made that very clear. Anyone who thinks otherwise isn’t paying attention – or doesn’t want to. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 27, 2021 Category: Pharmaceuticals Source Type: blogs
Addressing "Temporary" Insanity
I just googled “temporary vaccine waiver” under “news” and got 31,900 hits. Then I ran the same exercise for “Pfizer and BioNTech Announce Collaboration with Biovac to Manufacture and Distribute COVID-19 Vaccine Doses within Africa.” I got 1300 hits. That’s upside down and unfortunate since it’s th e Pfizer/BioNTech announcement that’s going to save lives. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 23, 2021 Category: Pharmaceuticals Source Type: blogs
About that FDA Report on Third Party Medical Device Servicing
The “Right to Repair” issue pertains to FDA-regulated medical devices and the unintended negative consequences for patient health and safety that would result if unregulated third-parties were allowed to work on these highly sophisticated pieces of equipment. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 20, 2021 Category: Pharmaceuticals Source Type: blogs
Are We Suffering From COVID Overreaction??
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - August 17, 2020 Category: Pharmaceuticals Source Type: blogs
Copay Accumulators. Soon to be banned in Boston?
The Massachusetts Health Policy Commission examined copay accumulators and the use and impact of prescription drug coupons in Massachusetts. Of note, the study finds that, “Continued growth in high deductible plan enrollment, coupled with increasing drug prices, suggests that patient affordability challenges will only increase. Eliminating the availability of coupons at this time – without substantial protections for patient affordability – would likely create s erious challenges for many patients in the Commonwealth.” (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 7, 2020 Category: Pharmaceuticals Source Type: blogs
Patients Rising Podcast on Safer and Cheaper Drugs With Janet Woodcock
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - June 23, 2020 Category: Pharmaceuticals Source Type: blogs
The QALY is Discriminatory
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - June 23, 2020 Category: Pharmaceuticals Source Type: blogs
The Young and the COVID Restless
Conclusion – Smart opening must be matched with enhanced personal responsibility. What messages are most useful and impactful for un-masked youth? (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - June 21, 2020 Category: Pharmaceuticals Source Type: blogs
Silencing Science
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - June 11, 2020 Category: Pharmaceuticals Source Type: blogs
FDA and Media Spreads Fear About Fake Vape-COVID Connection
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - April 6, 2020 Category: Pharmaceuticals Source Type: blogs
POTUS gets a Warning Letter
If a pharmaceutical company actively promotes one of its products for conditions other than those approved by the Food and Drug Administration, it ’s considered “violative behavior” and often results in what’s known in the regulatory world as a “warning letter” -- official correspondence from the FDA ordering the firm to cease and desist from such communications. But can the FDA send a warning letter to the President of the United States? (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - April 6, 2020 Category: Pharmaceuticals Source Type: blogs
Part D Rebates: Nothing but Net
A new Schaeffer Center white paper finds almost half of individuals with Medicare Part D coverage would see a reduction in out-of-pocket spending if patient cost-sharing were based on the price negotiated after the rebate (or net price), rather than the pre-rebate list price. (Source: drugwonks.com Blog)
Source: drugwonks.com Blog - March 18, 2020 Category: Pharmaceuticals Source Type: blogs
Occam's Co-Pay
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - March 12, 2020 Category: Pharmaceuticals Source Type: blogs
How the Media Enables ICER's Evil Agenda
(Source: drugwonks.com Blog)
Source: drugwonks.com Blog - July 25, 2019 Category: Pharmaceuticals Source Type: blogs
